Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Goodwill (2019 - 2025)

Historic Goodwill for Orthopediatrics (KIDS) over the last 7 years, with Q3 2025 value amounting to $103.6 million.

  • Orthopediatrics' Goodwill rose 1353.36% to $103.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $103.6 million, marking a year-over-year increase of 1353.36%. This contributed to the annual value of $93.8 million for FY2024, which is 1212.08% up from last year.
  • Latest data reveals that Orthopediatrics reported Goodwill of $103.6 million as of Q3 2025, which was up 1353.36% from $99.0 million recorded in Q2 2025.
  • Orthopediatrics' 5-year Goodwill high stood at $103.6 million for Q3 2025, and its period low was $68.5 million during Q1 2021.
  • Over the past 5 years, Orthopediatrics' median Goodwill value was $84.1 million (recorded in 2023), while the average stood at $83.9 million.
  • Per our database at Business Quant, Orthopediatrics' Goodwill skyrocketed by 35103.76% in 2021 and then crashed by 812.09% in 2023.
  • Orthopediatrics' Goodwill (Quarter) stood at $72.3 million in 2021, then grew by 20.0% to $86.8 million in 2022, then dropped by 3.6% to $83.7 million in 2023, then increased by 12.12% to $93.8 million in 2024, then increased by 10.41% to $103.6 million in 2025.
  • Its last three reported values are $103.6 million in Q3 2025, $99.0 million for Q2 2025, and $93.7 million during Q1 2025.